Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - October 26, 2022 Category: Allergy & Immunology Authors: Andrew X Zhu Yong Lin David Ferry Ryan C Widau Abhijoy Saha Source Type: research
Role of allogeneic natural killer T cells in the treatment of a patient with gefitinib-sensitive lung adenocarcinoma
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 28, 2022 Category: Allergy & Immunology Authors: Wanjun Yu Xiao Yuan Fei Ye Chaoming Mao Jian Li Minghui Zhang Deyu Chen Sheng Xia Source Type: research
Systemic IgG exposure and safety in patients with primary immunodeficiency: a randomized crossover study comparing a novel investigational wearable infusor versus the Crono pump
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 21, 2022 Category: Allergy & Immunology Authors: Richard L Wasserman Charlotte Cunningham-Rundles John Anderson Patricia Lugar Michael Palumbo Niraj C Patel Jutta Hofmann Fiona Glassman Eileen Rogers Michaela Praus Mikhail A Rojavin Source Type: research
Corrigendum
Immunotherapy,Volume 14, Issue 14, Page 1181-1181, October 2022. (Source: Immunotherapy)
Source: Immunotherapy - September 15, 2022 Category: Allergy & Immunology Source Type: research
Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 13, 2022 Category: Allergy & Immunology Authors: Barbora Turkov á Jan Tu žil Barbora Piln áčková Helena Dole žalová Daniela Štrosová V ít Petrů Ester Seberov á Tom áš Doležal Source Type: research
Enhancement of dendritic cell immunotherapy by recalling antigens for hepatocellular carcinoma in mice
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 13, 2022 Category: Allergy & Immunology Authors: Wei-Chen Lee Chih-Hsien Cheng Chen-Fang Lee Hsiu-Ying Hsu Pao-Yueh Hsu Ting-Jung Wu Kun-Ming Chan Source Type: research
Efficacy of long-term repeated rituximab treatment in refractory phospholipase A2 receptor-antibody-related membranous nephropathy
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 13, 2022 Category: Allergy & Immunology Authors: Lihua Zhang Mengxing Chen Weibo Le Mingchao Zhang Yuanmao Tu Ke Zuo Dacheng Chen Yan Wu Shijun Li Caihong Zeng Zhen Cheng Honglang Xie Source Type: research
Fatal toxicity induced by anti-PD-1 immune checkpoint inhibitor in thymic epithelial tumor
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 12, 2022 Category: Allergy & Immunology Authors: Xuquan Jing Hui Zhu Yuying Li Wenxiao Jia Xiaoyang Zhai Ji Li Jinming Yu Source Type: research
Plain language summary of the VOLTAIRE-RA study in patients with moderate-to-severe rheumatoid arthritis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 6, 2022 Category: Allergy & Immunology Authors: Stanley B Cohen Eric C Lee Source Type: research
Plain language summary of the VOLTAIRE-RA in patients with moderate-to-severe rheumatoid arthritis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 6, 2022 Category: Allergy & Immunology Authors: Stanley B Cohen Eric C Lee Source Type: research
Immunotherapy in atopic dermatitis
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 1, 2022 Category: Allergy & Immunology Authors: Wei Li Xiao-Yong Man Source Type: research
Safety of subcutaneous immunotherapy with carbamylated allergoids based on data from a pharmacovigilance database
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 1, 2022 Category: Allergy & Immunology Authors: Frati Franco Incorvaia Cristoforo Silvestri Francesca Pisani Arianna Marastoni Laura Cavalieri Carlo Masieri Simonetta Compalati Enrico Source Type: research
Effect of neoadjuvant therapy on tumor tissue PD-L1 and VISTA expression levels in non-small-cell lung cancer
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - September 1, 2022 Category: Allergy & Immunology Authors: Orhun Akdo ğan Osman S ütcüoğlu Bet ül Öğüt Nalan Aky ürek Nuriye Özdemir Ahmet Özet Ozan Yaz ıcı Source Type: research
Harnessing gene fusion-derived neoantigens for ‘cold’ breast and prostate tumor immunotherapy
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - August 31, 2022 Category: Allergy & Immunology Authors: Ravi Velaga Kevin M Koo Paul N Mainwaring Source Type: research
Complete remission of ovarian clear cell carcinoma achieved after pseudoprogression during PD-1 inhibitor therapy
Immunotherapy, Ahead of Print. (Source: Immunotherapy)
Source: Immunotherapy - August 31, 2022 Category: Allergy & Immunology Authors: Baozhen Ma Lingdi Zhao Yong Zhang Fang Zhang Quanli Gao Source Type: research
